Product information

Current status:

Cancelled Pre Market

Current status date:

2015-10-16

Original market date: ^{See footnote 1}

Product name:

RATIO-NAPROXEN E

DIN:

02231004 Electronic product monograph is not available

Company:

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Tablet (Enteric-Coated)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:08.04.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

M01AE02 NAPROXEN

Active ingredient group (AIG) number:^{See footnote5}

0109634001